Also see: Oracle, Gen-Probe: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.



) --


Advanced Auto Parts

(AAP) - Get Advance Auto Parts, Inc. Report

price target cut at Citi to $65 from $70. 1Q below street, consumers increasingly price sensitive, Citigroup said. Maintain Hold rating.


(CMCSA) - Get Comcast Corporation Class A Report

added to Top Picks Live at Citi. Buybacks likely and strong financial flexibility, Citigroup said. Maintain Buy rating and $29 price target.


(COST) - Get Costco Wholesale Corporation Report

estimates lowered at Morgan Stanley. COST estimates were cut through 2013, Morgan Stanley said. Company is facing higher LIFO charges. Overweight rating and $90 price target.

Johnson & Johnson

(JNJ) - Get Johnson & Johnson (JNJ) Report

numbers raised at UBS. Shares of JNJ now seen reaching $75, according to UBS. Estimates also increased, as the company can generate better organic growth in the coming quarters. Buy rating.


(NTAP) - Get NetApp, Inc. (NTAP) Report

estimates upped at Morgan Stanley through 2013. Business trends are improving. Equal-weight rating.

TheStreet Recommends

PSS World Medical


numbers increased at Goldman. PSSI estimates were raised through 2014. Higher revenue is driving margin growth. Neutral rating and new $28 price target.

Polo Ralph Lauren

(RL) - Get Ralph Lauren Corporation Class A Report

price target cut at Citi to $140 from $148. Fundamentals remain intact despite 4Q miss and new guidance, Citigroup said. Maintain Buy rating.

Sandridge Energy

(SD) - Get SandRidge Energy, Inc. Report

estimates cut at UBS through 2012. Company is realizing lower production but has closed its funding gap. Neutral rating and $11.50 price target.


(SMTC) - Get Semtech Corporation Report

estimates, target boosted at Goldman. Shares of SMTC now seen reaching $28, according to Goldman Sachs. Estimates also upped, to match the company's new guidance. Neutral rating.

Toll Brothers

(TOL) - Get Toll Brothers, Inc. Report

numbers raised at Goldman. Shares of TOL now seen reaching $20, according to Goldman Sachs. Estimates also increased, given better sentiment for the high-end of the housing market. Neutral rating.



cut from Conviction List at Goldman Sachs. Valuation call, as the stock is up 34% over the past year. $48 price target.

Watson Pharmaceuticals


price target boosted at Citi to $72 from $67. Specifar accretion substantially underestimated, Citigroup said. Maintain Buy rating.

This article was written by a staff member of TheStreet.